Limited existing data in this regard shows that in such patients, AQP4-IgG detection rates are similar to those observed in patients with NMOSD without associated rheumatic disease, suggesting LETM in NMOSD is not secondary to SLE or SS, and these patients suffer from two independent, coexisting autoimmune diseases [118,141,142,143]. Here, AQP4 is linked to autoimmune disease.